← Back
$CRNX All transactions

Crinetics Pharmaceuticals, Inc.

M 10b5-1 Plan

$ Value

$0

Shares

5,000

Price

$0

Filed

Dec 3

Insider

Name

Pizzuti Dana

Title

Chief Med and Dev Officer

CIK

0001948238

Roles

Officer

Transaction Details

Transaction Date

2025-12-01

Code

M

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

69,042

Footnotes

Includes 567 shares acquired under the Issuer's Employee Stock Purchase Plan. | The sale reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 21, 2025. | The common stock was sold by the Reporting Person in open market transactions on the transaction date, with a volume weighted average sale price of $45.02 per share. The range of sale prices on the transaction date was $44.59 to $45.51. Detailed information on the exact number of shares can be obtained from the Issuer upon request. | The option is exercisable as follows: 25% of the shares subject to the option vested on September 30, 2023, and the remaining number of shares subject to the option vest monthly thereafter in thirty-six equal monthly installments, subject to the Reporting Person's continued employment with the Issuer on each such vesting date.

Filing Info

Accession No.

0001628280-25-055054

Form Type

4

Issuer CIK

0001658247

Pizzuti Dana's History

Date Ticker Type Value
2025-12-01 CRNX M $84K
2025-12-01 CRNX $225K
2025-12-01 CRNX M $0
2025-11-03 CRNX M $84K
2025-11-03 CRNX $209K
2025-11-03 CRNX $4K
2025-11-03 CRNX M $0
2025-10-01 CRNX M $84K
2025-10-01 CRNX $209K
2025-10-01 CRNX M $0

Other Insiders at CRNX (90d)

Insider Bought Sold Last
Knight Jeff E.
Chief Dev. & Operating Officer
$3.4M 2026-04-08